Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study
Authors
Keywords
-
Journal
ANNALS OF THE RHEUMATIC DISEASES
Volume 79, Issue 5, Pages 595-604
Publisher
BMJ
Online
2020-04-07
DOI
10.1136/annrheumdis-2020-216980
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials
- (2019) Stefan Schreiber et al. ANNALS OF THE RHEUMATIC DISEASES
- 2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis
- (2019) Michael M. Ward et al. ARTHRITIS CARE & RESEARCH
- Immune cells involved in the pathogenesis of ankylosing spondylitis
- (2018) Alireza Rezaiemanesh et al. BIOMEDICINE & PHARMACOTHERAPY
- Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial
- (2018) Kim A. Papp et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Clinical Responses and Synovial Vascularity in Obese Rheumatoid Arthritis Patients Treated with Adalimumab and Methotrexate
- (2018) Gurjit S. Kaeley et al. JOURNAL OF RHEUMATOLOGY
- Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial
- (2018) Désirée van der Heijde et al. LANCET
- Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis: 52-week Results from a Phase III Study (SPIRIT-P1)
- (2017) Désirée van der Heijde et al. JOURNAL OF RHEUMATOLOGY
- Axial spondyloarthritis
- (2017) Joachim Sieper et al. LANCET
- Sexual Dimorphism in the Th17 Signature of Ankylosing Spondylitis
- (2016) Eric Gracey et al. Arthritis & Rheumatology
- Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
- (2015) Dominique Baeten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study
- (2013) R Landewé et al. ANNALS OF THE RHEUMATIC DISEASES
- Sleep disturbances are associated with increased pain, disease activity, depression, and anxiety in ankylosing spondylitis: a case-control study
- (2012) Yan Li et al. ARTHRITIS RESEARCH & THERAPY
- A stratified model for health outcomes in ankylosing spondylitis
- (2011) P. Machado et al. ANNALS OF THE RHEUMATIC DISEASES
- Physical Fitness in Patients With Ankylosing Spondylitis: Comparison With Population Controls
- (2011) Silje Halvorsen et al. PHYSICAL THERAPY
- Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores
- (2010) P. Machado et al. ANNALS OF THE RHEUMATIC DISEASES
- Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial
- (2008) D van der Heijde et al. ANNALS OF THE RHEUMATIC DISEASES
- Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine
- (2008) R Landewe et al. ANNALS OF THE RHEUMATIC DISEASES
- Regulation of inflammatory responses by IL-17F
- (2008) Xuexian O. Yang et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now